SEC Form 4 · accession 0001246360-15-001232
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Feb 25, 2015
Accepted (ET)
Feb 26, 2015 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2015 | M | 132 | $4.54 | A | 112,707 | D | |
| Common Stock | Feb 25, 2015 | M | 150 | $2.11 | A | 112,857 | D | |
| Common Stock | Feb 25, 2015 | M | 800 | $9.96 | A | 113,657 | D | |
| Common Stock | Feb 25, 2015 | S | 2,082 | $17.88 | D | 111,575 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $4.54 | Feb 25, 2015 | M | 132 | D | Apr 27, 2008 | Mar 26, 2015 | Common Stock | 132 | 268 | D |
| Stock Option (Right to Buy) | $2.11 | Feb 25, 2015 | M | 150 | D | Apr 5, 2009 | Mar 4, 2016 | Common Stock | 150 | 8,661 | D |
| Stock Option (Right to Buy) | $9.96 | Feb 25, 2015 | M | 800 | D | Apr 3, 2010 | Mar 2, 2017 | Common Stock | 800 | 36,400 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2014.